Osaic Holdings’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Sell |
75,364
-1,575
| -2% | -$3.47K | ﹤0.01% | 3743 |
|
|
2025
Q1 | $111K | Sell |
76,939
-435
| -0.6% | -$626 | ﹤0.01% | 4087 |
|
|
2024
Q4 | $170K | Buy |
77,374
+744
| +1% | +$1.64K | ﹤0.01% | 3739 |
|
|
2024
Q3 | $126K | Sell |
76,630
-5,950
| -7% | -$9.82K | ﹤0.01% | 4035 |
|
|
2024
Q2 | $183K | Buy |
82,580
+3,950
| +5% | +$8.77K | ﹤0.01% | 3634 |
|
|
2024
Q1 | $211K | Buy |
78,630
+6,536
| +9% | +$17.5K | ﹤0.01% | 3630 |
|
|
2023
Q4 | $216K | Buy |
72,094
+727
| +1% | +$2.17K | ﹤0.01% | 3864 |
|
|
2023
Q3 | $69.9K | Buy |
71,367
+6,736
| +10% | +$6.6K | ﹤0.01% | 4757 |
|
|
2023
Q2 | $89.8K | Buy |
64,631
+4,708
| +8% | +$6.54K | ﹤0.01% | 4522 |
|
|
2023
Q1 | $95.3K | Buy |
59,923
+1,299
| +2% | +$2.07K | ﹤0.01% | 4490 |
|
|
2022
Q4 | $366K | Buy |
58,624
+51,801
| +759% | +$323K | ﹤0.01% | 3315 |
|
|
2022
Q3 | $47K | Buy |
6,823
+3,240
| +90% | +$22.3K | ﹤0.01% | 4948 |
|
|
2022
Q2 | $24K | Buy |
3,583
+62
| +2% | +$415 | ﹤0.01% | 5472 |
|
|
2022
Q1 | $16K | Sell |
3,521
-62
| -2% | -$282 | ﹤0.01% | 5809 |
|
|
2021
Q4 | $18K | Buy |
3,583
+119
| +3% | +$598 | ﹤0.01% | 5828 |
|
|
2021
Q3 | $42K | Hold |
3,464
| – | – | ﹤0.01% | 5225 |
|
|
2021
Q2 | $73K | Sell |
3,464
-95
| -3% | -$2K | ﹤0.01% | 4750 |
|
|
2021
Q1 | $99K | Sell |
3,559
-387
| -10% | -$10.8K | ﹤0.01% | 4346 |
|
|
2020
Q4 | $102K | Sell |
3,946
-5,106
| -56% | -$132K | ﹤0.01% | 4011 |
|
|
2020
Q3 | $404K | Sell |
9,052
-1,185
| -12% | -$52.9K | ﹤0.01% | 2630 |
|
|
2020
Q2 | $526K | Buy |
10,237
+1,785
| +21% | +$91.7K | ﹤0.01% | 2310 |
|
|
2020
Q1 | $270K | Buy |
+8,452
| New | +$270K | ﹤0.01% | 2615 |
|